SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001140361-22-036678
Filing Date
2022-10-07
Accepted
2022-10-07 17:29:15
Documents
1
Group Members
DAVID C. OTTO. ANDREAS HALVORSENROSE S. SHABETVIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LPVIKING GLOBAL OPPORTUNITIES DRAWDOWN GP LLCVIKING GLOBAL OPPORTUNITIES DRAWDOWN PORTFOLIO GP LLCVIKING GLOBAL OPPORTUNITIES GP LLCVIKING GLOBAL OPPORTUNITIES

Document Format Files

Seq Description Document Type Size
1 SC 13G brhc10042790_sc13g.htm SC 13G 390680
  Complete submission text file 0001140361-22-036678.txt   392693
Mailing Address 55 RAILROAD AVENUE GREENWICH CT 06830
Business Address 55 RAILROAD AVENUE GREENWICH CT 06830 212-672-7050
VIKING GLOBAL INVESTORS LP (Filed by) CIK: 0001103804 (see all company filings)

IRS No.: 134055118 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Subject) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91005 | Film No.: 221301575
SIC: 2834 Pharmaceutical Preparations